| Abstract:Objective To analyze the economic burden of patients with multidrug-resistant organism（MDRO）nosocomial infection according to diagnosis related groups（DRGs）. Methods Retrospective analysis was used to analyze the hospitalization days and hospitalization expenses of nosocomial infection cases of MDRO in hospitalized patients in a third class a general hospital in 2020 and 2021 year, and compared with the same group of non-infected patients with DRGs in the same period. Results In 2020 and 2021 year, the average length of stay and the average cost of hospitalization in the MDRO nosocomial infection group were significantly higher than the same group of non-infected patients with DRGs, with statistical significance（P<0.05）.From the site of infection，the average length of stay and the average cost of hospitalization of the six groups of respiratory system, bacteremia, urinary system, abdominal and pelvic cavity, digestive system and catheter-related infection were higher than the same group of non-infected patients with DRGs in the same period in two years, with statistical significance（P<0.05）.In terms of infection departments, the top six were ICU, hepatological surgery department, nephrology department, medical oncology, hematology department and infectious disease department. The six departments were MDRO hospital infection key management department, because they accounted for a high proportion of the number of cases of MDRO nosocomial infection, the total length of stay and the total hospitalization cost in the whole hospital. Conclusion The nosocomial infection of MDRO in hospitalized patients will prolong the hospitalization time, increase the hospitalization expenses and increase the economic burden of patients. Based on the DRGs group payment model, hospitals should analyze the data of high-risk sites and departments of MDRO nosocomial infection, formulate targeted intervention measures and implement them effectively, so as to reduce the economic burden of patients and improve the quality of medical treatment. |
